| Product Code: ETC7496752 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Overview |
3.1 Hungary Country Macro Economic Indicators |
3.2 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market - Industry Life Cycle |
3.4 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market - Porter's Five Forces |
3.5 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.9 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Technological advancements in next-generation sequencing (NGS) technologies |
4.2.3 Growing prevalence of chronic diseases and genetic disorders in Hungary |
4.3 Market Restraints |
4.3.1 High cost associated with NGS testing procedures |
4.3.2 Lack of skilled professionals in the field of clinical NGS testing |
5 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Trends |
6 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market, By Types |
6.1 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing By Synthesis, 2021- 2031F |
6.1.4 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Ion Semiconductor Sequencing, 2021- 2031F |
6.1.5 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single-Molecule Real-time Sequencing, 2021- 2031F |
6.1.6 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Nano Pore Sequencing, 2021- 2031F |
6.1.7 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Technologies, 2021- 2031F |
6.2 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.2.3 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.2.4 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Agricultural and Animal Research, 2021- 2031F |
6.2.5 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.3 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Academic Institutes and Research Centres, 2021- 2031F |
6.3.3 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.4 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.3.5 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other End Users, 2021- 2031F |
6.4 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market, By Service |
6.4.1 Overview and Analysis |
6.4.2 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Human Genome Sequencing, 2021- 2031F |
6.4.3 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single Cell Sequencing, 2021- 2031F |
6.4.4 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Microbial Genome-based Sequencing, 2021- 2031F |
6.4.5 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Gene Regulation Services, 2021- 2031F |
6.4.6 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Animal and Plant Sequencing, 2021- 2031F |
6.4.7 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Services, 2021- 2031F |
6.5 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market, By Workflow |
6.5.1 Overview and Analysis |
6.5.2 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.5.3 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.5.4 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Data Analysis, 2021- 2031F |
7 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Import-Export Trade Statistics |
7.1 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Export to Major Countries |
7.2 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Imports from Major Countries |
8 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing results |
8.2 Number of accredited laboratories offering clinical NGS testing services in Hungary |
8.3 Rate of adoption of NGS testing in clinical settings |
9 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market - Opportunity Assessment |
9.1 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Service, 2021 & 2031F |
9.5 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market - Competitive Landscape |
10.1 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Revenue Share, By Companies, 2024 |
10.2 Hungary Clinical Next-Generation Sequencing (NSG) Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here